ADD CONDITION

items per page

Mucosan Multi-Symptom Honey

Last content change checked dailysee data sync status

Active ingredients
  • Guaifenesin 100 mg/5 mL
  • Dextromethorphan Hydrobromide 10 mg/5 mL
  • Phenylephrine Hydrochloride 5 mg/5 mL
Other brand names
Drug classes
Expectorant, Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist, alpha-1 Adrenergic Agonist
Dosage form
Liquid
Route
Oral
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2024
Label revision date
January 8, 2026
Active ingredients
  • Guaifenesin 100 mg/5 mL
  • Dextromethorphan Hydrobromide 10 mg/5 mL
  • Phenylephrine Hydrochloride 5 mg/5 mL
Other brand names
Drug classes
Expectorant, Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist, alpha-1 Adrenergic Agonist
Dosage form
Liquid
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2024
Label revision date
January 8, 2026
Manufacturer
Menper Distributors, Inc.
Registration number
M012
NDC root
53145-695

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Mucosan Honey is a product designed to help loosen phlegm (mucus) and thin bronchial secretions, making it easier for you to drain your bronchial tubes. It works by temporarily relieving nasal congestion and alleviating cough caused by minor irritation in the throat and bronchial area. This can provide comfort when you're dealing with respiratory discomfort.

Uses

This medication is designed to help you breathe easier by loosening phlegm (mucus) and thinning bronchial secretions, which allows for better drainage of your bronchial tubes. If you're experiencing symptoms from a cold, such as nasal congestion or a cough caused by minor irritation in your throat and bronchial area, this medication can provide temporary relief.

It's important to note that there are no reported teratogenic effects (harmful effects on fetal development) or nonteratogenic effects (not harmful to fetal development) associated with this medication. This means it is considered safe in those respects.

Dosage and Administration

When using this medication, it's important to follow the dosing instructions carefully. For adults and children aged 12 years and older, you should take 2 teaspoons (10 mL) every 4 hours. However, make sure not to exceed 6 doses within a 24-hour period. This product is specifically designed for adults and is not suitable for children under 12 years of age.

To ensure accurate dosing, always use the dosing cup that comes with the product. It's a good idea to keep the dosing cup with the medication so you can easily measure the correct amount each time you need to take it. Remember, safety first—never use this medication for children under 12.

What to Avoid

If you experience nervousness, dizziness, or sleeplessness while using this medication, it's important to stop taking it and consult your doctor. Additionally, if your symptoms do not improve within 7 days or if they are accompanied by a fever, you should also seek medical advice. Be sure to stop use and contact your healthcare provider if your cough lasts more than a week, returns, or is accompanied by a fever, rash, or a persistent headache. Your health and safety are paramount, so don’t hesitate to reach out for help if you have any concerns.

Side Effects

If you experience nervousness, dizziness, or sleeplessness while using this medication, it's important to stop using it and consult your doctor. Additionally, if your symptoms do not improve within 7 days, or if they are accompanied by a fever, you should seek medical advice. A cough that lasts more than 7 days, returns, or is accompanied by fever, rash, or a persistent headache may indicate a more serious condition, and you should also reach out to a healthcare professional in these cases.

Warnings and Precautions

You should not use this medication if you are currently taking a prescription monoamine oxidase inhibitor (MAOI), which is a type of drug used for depression, psychiatric conditions, or Parkinson's disease. Additionally, you must wait at least two weeks after stopping an MAOI before using this product. If you're unsure whether your prescription contains an MAOI, please consult your doctor or pharmacist.

If you experience nervousness, dizziness, or sleeplessness, stop taking the medication and call your doctor. You should also reach out to your doctor if your symptoms do not improve within seven days, or if they are accompanied by a fever. If your cough lasts more than seven days, returns, or is accompanied by fever, rash, or a persistent headache, these could indicate a more serious issue.

In the event of an overdose, it is crucial to seek emergency medical help or contact a Poison Control Center immediately.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's important to be aware of the general signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect an overdose, it is crucial to seek immediate medical attention.

In case of an emergency, call your local emergency services or go to the nearest hospital. Always keep your medications in a safe place and follow the prescribed dosage to prevent any potential risks. If you have any concerns or questions about your medication, don’t hesitate to reach out to your healthcare provider for guidance.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

This product is designed for adults and should not be used in children under 12 years of age. If you have a child younger than 12, it’s important to avoid using this medication, as it is not intended for their use. Always consult with a healthcare professional if you have questions about appropriate treatments for your child.

Geriatric Use

If you are an older adult or caring for one, it's important to know that this medication is not suitable for children under 12 years old. Before using it, you should consult a doctor if you have any heart conditions, high blood pressure, thyroid issues, diabetes, or difficulty urinating due to an enlarged prostate.

Be sure to follow the recommended dosage carefully and do not exceed it. If you experience feelings of nervousness, dizziness, or sleeplessness, stop using the medication and consult your doctor. Additionally, if your symptoms do not improve within 7 days, or if they are accompanied by a fever, rash, or persistent headache, seek medical advice, as these could indicate a more serious health issue.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.

It's always best to discuss your individual situation with your healthcare provider, who can offer personalized advice and ensure that any medications you take are safe and effective for you.

Hepatic Impairment

If you have liver problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or precautions related to your condition. This means that there are no tailored recommendations for how the medication may affect you differently due to your liver health.

Always consult your healthcare provider for personalized advice and to ensure that any treatment plan is safe and effective for your specific situation. They can help determine the best approach based on your liver function and overall health.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you. Always share your complete list of medications and any recent lab tests to avoid any potential issues. Your health and safety should always come first.

Storage and Handling

To ensure the best performance of your product, store it at a temperature between 15-30°C (59-86ºF). It's important not to refrigerate the product, as this can affect its effectiveness.

When handling the product, make sure to do so in a clean environment to maintain its integrity. Always follow any additional safety instructions provided to ensure safe use and disposal.

Additional Information

No further information is available.

FAQ

What is Mucosan Honey used for?

Mucosan Honey helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes, temporarily relieving nasal congestion and cough due to minor throat and bronchial irritation.

Who should not use Mucosan Honey?

This product is not intended for use in children under 12 years of age.

What is the recommended dosage for adults and children over 12?

Adults and children 12 years and over should take 2 teaspoons (10 mL) every 4 hours, not exceeding 6 doses in any 24-hour period.

What should I do if my symptoms do not improve?

Stop use and ask a doctor if symptoms do not get better within 7 days or are accompanied by fever.

Are there any side effects I should be aware of?

Stop use and ask a doctor if you experience nervousness, dizziness, sleeplessness, or if your cough lasts more than 7 days or is accompanied by fever, rash, or persistent headache.

Can I use Mucosan Honey if I am pregnant or breastfeeding?

If you are pregnant or breastfeeding, ask a health professional before use.

What should I do in case of an overdose?

In case of overdose, get medical help or contact a Poison Control Center right away.

What should I do if I am taking other medications?

Do not use Mucosan Honey if you are currently taking a prescription monoamine oxidase inhibitor (MAOI) or for 2 weeks after stopping an MAOI drug. Consult a doctor or pharmacist if unsure.

Packaging Info

Below are the non-prescription pack sizes of Mucosan Multi-Symptom Honey (dextromethorphan hbr, guaifenesin, phenylephrine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Mucosan Multi-Symptom Honey.
Details

Drug Information (PDF)

This file contains official product information for Mucosan Multi-Symptom Honey, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the relief of symptoms associated with colds, specifically nasal congestion and cough due to minor throat and bronchial irritation. It aids in loosening phlegm (mucus) and thinning bronchial secretions, facilitating drainage of the bronchial tubes.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The maximum recommended dosage for adults and children aged 12 years and older is 2 teaspoons (10 mL) every 4 hours, with a limit of 6 doses within a 24-hour period. This product is not intended for use in children under 12 years of age.

Healthcare professionals should instruct patients to measure the dosage using the dosing cup provided with the product, ensuring that the dosing cup remains with the product for accurate measurement. It is essential to adhere to the specified dosing guidelines to avoid potential overdose.

Contraindications

Use of this product is contraindicated in patients who experience nervousness, dizziness, or sleeplessness. If these symptoms occur, discontinue use and consult a healthcare professional.

Additionally, if symptoms do not improve within 7 days or are accompanied by fever, medical advice should be sought. Patients should also stop use and consult a doctor if a cough persists for more than 7 days, recurs, or is associated with fever, rash, or a persistent headache.

Warnings and Precautions

It is imperative that this product not be used concurrently with prescription monoamine oxidase inhibitors (MAOIs), which are medications prescribed for depression, psychiatric or emotional conditions, or Parkinson's disease. Additionally, the use of this product is contraindicated for a period of two weeks following the discontinuation of an MAOI. Healthcare professionals should advise patients to consult with a doctor or pharmacist if there is any uncertainty regarding the presence of an MAOI in their current prescription medications.

Patients should be instructed to discontinue use and seek medical attention if they experience symptoms such as nervousness, dizziness, or insomnia. Furthermore, if symptoms do not improve within seven days or are accompanied by fever, or if a cough persists beyond seven days, recurs, or is associated with fever, rash, or a persistent headache, patients must contact their healthcare provider. These symptoms may indicate a more serious underlying condition that requires further evaluation.

In the event of an overdose, it is crucial to obtain emergency medical assistance immediately or to contact a Poison Control Center without delay. Prompt action is essential to ensure patient safety and effective management of the situation.

Side Effects

Patients should discontinue use and consult a healthcare professional if they experience symptoms such as nervousness, dizziness, or sleeplessness. Additionally, if symptoms do not improve within 7 days or are accompanied by fever, medical advice should be sought. A cough that persists for more than 7 days, recurs, or is associated with fever, rash, or a persistent headache may indicate a serious underlying condition and warrants immediate medical evaluation.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Mucosan Multi-Symptom Honey (dextromethorphan hbr, guaifenesin, phenylephrine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Mucosan Multi-Symptom Honey.
Details

Pediatric Use

This adult strength product is not intended for use in pediatric patients under 12 years of age. The safety and efficacy of this medication have not been established in children under this age. Therefore, it is contraindicated for use in this population.

Geriatric Use

Elderly patients may require special consideration when using this adult strength product, which is not intended for use in individuals under 12 years of age. Prior to use, it is advisable for geriatric patients to consult a healthcare provider, particularly if they have pre-existing conditions such as heart disease, high blood pressure, thyroid disease, diabetes, or urinary difficulties due to an enlarged prostate gland.

It is crucial for elderly patients to adhere strictly to the recommended dosage and to avoid exceeding it. Monitoring for adverse effects is important; patients should discontinue use and seek medical advice if they experience symptoms such as nervousness, dizziness, or sleeplessness. Additionally, if symptoms do not improve within 7 days, or if they are accompanied by fever, it is essential to consult a healthcare provider. Persistent cough lasting more than 7 days, or a cough that recurs or is associated with fever, rash, or a persistent headache, may indicate a serious underlying condition that requires prompt medical evaluation.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the safety of both the patient and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the text. Therefore, healthcare professionals should exercise caution and consider individual patient factors when prescribing to this population. Regular monitoring of renal function may be warranted in patients with reduced kidney function to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, remain observant for potential overdose symptoms, and implement appropriate management strategies as needed.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. No specific non-teratogenic effects have been identified in the available data. Additionally, there are no detailed findings regarding nonclinical toxicology or animal pharmacology and toxicology provided in the current information.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of an overdose, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Patients should be informed to discontinue use and consult a doctor if they experience symptoms such as nervousness, dizziness, or sleeplessness. Additionally, they should be advised to stop use and seek medical advice if their symptoms do not improve within 7 days or if they are accompanied by fever. It is important to inform patients that they should also stop use and consult a doctor if their cough persists for more than 7 days, returns, or is accompanied by fever, rash, or a persistent headache, as these may indicate a serious condition.

Healthcare providers should encourage patients to consult a doctor before using the medication if they have any of the following conditions: heart disease, high blood pressure, thyroid disease, diabetes, or difficulty urinating due to an enlarged prostate gland. Patients should also be advised to seek medical advice before use if they have a cough that produces excessive phlegm or if they have a chronic cough associated with smoking, asthma, chronic bronchitis, or emphysema.

Finally, patients should be reminded to consult a doctor or pharmacist before using this medication if they are currently taking any other oral nasal decongestants or stimulants to avoid potential interactions.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 15-30°C (59-86ºF). Refrigeration is not recommended, as it may compromise the integrity of the product. Proper handling and storage conditions must be adhered to in order to maintain product efficacy and safety.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Mucosan Multi-Symptom Honey, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Mucosan Multi-Symptom Honey, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.